The two organizations will produce educational materials about the medicine and its importance for people living with type 1 ...

The 2025 ADA Standards of Care includes ... to consider prescribing CGM for adults with type 2 diabetes treated with a glucose-lowering medication other than insulin. Bannuru said this ...

A groundbreaking development in diabetes treatment reveals that SGLT-2 inhibitors significantly reduce dementia risk among type 2 diabetes patients. Recent research demonstrates these medications ...

Retatrutide targets GIP and GLP-1 – the same as Lilly’s fast-growing diabetes ... ADA, Pfizer revealed that it had decided to end the development of one of its once-daily oral GLP-1 agonist ...

CHICAGO and ARLINGTON, Va. - The American Diabetes Association and a national supporter, Xeris Pharmaceuticals, have formed a multi-year strategic partnership to reinforce the importance of prescribin ...

Xeris Pharmaceuticals has teamed up with the American Diabetes Association (ADA) to raise awareness of the importance of ...

The project, unveiled at the ADA’s 76 th Scientific Sessions ... would come in three forms: a cognitive diabetes database intended to better inform treatment and care decisions by healthcare ...

The US Food and Drug Administration on Tuesday approved Ozempic for adults with type 2 diabetes and chronic kidney disease (CKD). The drug is now indicated specifically to treat kidney failure, ...

WASHINGTON — Medicare officials announced plans to negotiate the prices of blockbuster diabetes and weight loss drugs Ozempic ...